Clinical trial
Retrospective Study of the Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
NCT07433400 is registered in ClinicalTrials.gov with Group for Research in Adult Acute Lymphoblastic Leukemia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of the Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL
- Lead sponsor
- Group for Research in Adult Acute Lymphoblastic Leukemia
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 29, 2025
- Completion date
- December 31, 2035
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ph positive all